# Hemodynamic Response to Pain During Retinopathy Of Prematurity Screening

> **NCT05666362** · PHASE4 · COMPLETED · sponsor: **Alexandria University** · enrollment: 68 (actual)

## Conditions studied

- Preterm

## Interventions

- **DRUG:** benoxinate hydrochloride 0.4% group
- **DRUG:** saline 0.9% .

## Key facts

- **NCT ID:** NCT05666362
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-20
- **Primary completion:** 2024-12-20
- **Final completion:** 2025-01-15
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2025-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05666362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05666362, "Hemodynamic Response to Pain During Retinopathy Of Prematurity Screening". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05666362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*